Results 161 to 170 of about 19,125 (215)

Patients with Cancer and Immune Checkpoint Inhibitor-Induced Rheumatic irAEs Treated by DMARDs: The RHUMICI Single-Centre Retrospective Cohort. [PDF]

Cancers (Basel)
Massy E, Seiller J, Piperno M, Bonnelye E, Maillet D, Dalle S, Fontaine-Delaruelle C, Souquet PJ, Péron J, Confavreux CB.   +9 more
europepmc   +1 more source

Sex differences in long-term functional deterioration and permanent disability in spondyloarthritis: a 17-year follow-up from the REGISPON-3 study. [PDF]

RMD Open
Moldovan DMM, Ladehesa-Pineda L, Puche-Larrubia MÁ, Ábalos-Aguilera MC, Ruiz-Vilchez D, Granados RE, Collantes-Sánchez CM, Escudero-Contreras A, REGISPON-3 Study Group, Collantes-Estévez E, López-Medina C.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pulmonary Disease Due to Antirheumatic Agents

Clinics in Chest Medicine, 1990
Drug-induced lung disease presents several diagnostic and therapeutic problems to the clinician. This is especially true in the case of lung disease associated with antirheumatic agents in which pulmonary disease may be due to the underlying disorder.
R J, Zitnik, J A, Cooper
exaly   +3 more sources

Safe Use of Antirheumatic Agents in Patients with Comorbidities

Rheumatic Disease Clinics of North America, 2012
The burden of comorbid diseases is high among patients with rheumatoid arthritis (RA). These are often systemic manifestations of RA but may be chronic conditions that predate or develop post-RA diagnosis. Increased mortality in RA is predominantly from nonarticular causes.
Ashima Mąkol
exaly   +3 more sources

Therapeutics of Antirheumatic Agents

American Journal of Health-System Pharmacy, 1980
Ronald P Evens
exaly   +4 more sources

Disease-modifying antirheumatic and immunoregulatory agents

Bailliere's Clinical Rheumatology, 1990
K D Rainsford
exaly   +3 more sources

Antirheumatic agents and leukocyte recruitment

Biochemical Pharmacology, 1999
Michael J Parnham
exaly   +2 more sources

A controlled study of chloroquine as an antirheumatic agent

Arthritis & Rheumatism, 1958
AbstractThe use of a double‐blind therapeutic study to determine the effects of chloroquine on rheumatoid arthritis demonstrated antirheumatic properties of this drug. The criteria of Lansbury were successfully combined with other objective measurements to provide data of statistical validity.
A S, COHEN, E, CALKINS
openaire   +2 more sources